Phaseline

Companies › Pacylex Pharmaceuticals

Pacylex Pharmaceuticals: clinical trials, targets and expected readouts

1 active drug program in 1 registered trial: 1 Phase 1; Oncology.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
zelenirstat (PCLX-001)
C/EBP alpha activator
CEBPAPhase 1Relapsed Adult AML–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT06613217zelenirstat (PCLX-001)Phase 1Relapsed Adult AMLOncologyMar 2026

Targets

CEBPA (1)

Companies with the same targets

–

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.